Plasmodium falciparum in vitro drug resistance selections and gene editing

Caroline L. Ng, David A. Fidock

Research output: Chapter in Book/Report/Conference proceedingChapter

8 Scopus citations


Malaria continues to be a global health burden, threatening over 40% of the world’s population. Drug resistance in Plasmodium falciparum, the etiological agent of the majority of human malaria cases, is compromising elimination efforts. New approaches to treating drug-resistant malaria benefit from defining resistance liabilities of known antimalarial agents and compounds in development and defining genetic changes that mediate loss of parasite susceptibility. Here, we present protocols for in vitro selection of drug-resistant parasites and for site-directed gene editing of candidate resistance mediators to test for causality.

Original languageEnglish (US)
Title of host publicationMethods in Molecular Biology
PublisherHumana Press Inc.
Number of pages18
StatePublished - 2019

Publication series

NameMethods in Molecular Biology
ISSN (Print)1064-3745
ISSN (Electronic)1940-6029


  • CRISPR/Cas9
  • Drug resistance
  • Gene editing
  • Malaria
  • Plasmodium falciparum
  • Selections
  • ZFN

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics


Dive into the research topics of 'Plasmodium falciparum in vitro drug resistance selections and gene editing'. Together they form a unique fingerprint.

Cite this